跳至主要内容
临床试验/JPRN-UMIN000016310
JPRN-UMIN000016310已完成未知

Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis - Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis

Kamezawa EYE CLINIC0 个研究点目标入组 50 人开始时间: 2015年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

50 patients with allergic conjunctivitis wearing CL were instilled for 8 weeks with BAK-free epinastine hydrochloride ophthalmic solution, and clinical efficacy and safety were examined. Itchy eye, conjunctival hyperemia and staining score of kerato and conjunctival membrane were significantly improved by ocular instillation on CL wearing, which results were similar to the previous reports. Ocular instillation on CL wearing highly satisfied the patients with allergic conjunctivitis, which resulted in the CL wearing time extended to the same level as before the morbidity.Furthermore, eye drop instillation on CL wearing didn't have harmful effects on CL fitting, there were no adverse events such as corneal and conjunctival epithelial disorder, which suggested no concern in safety. From the above results, it can be expected that ocular instillation on CL wearing with epinastine hydrochloride ophthalmic solution can be a treatment for improving the symptoms and clinical findings of allergic conjunctivitis without impairing safety and increasing patient satisfaction.

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The patient at the start of the test, it is determined that the continuously during the test period should not wear contact lenses 2)Females who are or may be pregnant, or lactating 3)Patients with a history of hypersensitivity to study drug or test material 4)Patient who the investigator considers ineligible for enrolment

研究者

发起方
Kamezawa EYE CLINIC

相似试验